✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Intra-Cellular Therapies Inc

Common Name
Intra-Cellular Therapies
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
860
Ticker
ITCI
Exchange
NASDAQ/NGS
Description
Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treat...

Intra-Cellular Therapies's Waste Data Preview

In 2023, Intra-Cellular Therapies conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2023
Total Waste Generated
2.25a
Total Waste Recovered
0.45a
Total Hazardous Waste Generated
1.8a
Non-Hazardous Waste Disposed
N/A
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Intra-Cellular Therapies’s Waste Management Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Intra-Cellular Therapies's Sustainability Report 2023

Insights into Intra-Cellular Therapies's Waste Treatment Practices

In 2023, Intra-Cellular Therapies generated a total of 2metric tonnes of waste.a

Of this amount, 20% of Intra-Cellular Therapies's total waste generated was recovered through methods such as recycling, reuse, or composting, while 80% was disposed of through landfilling, incineration, or combustion.a

Intra-Cellular Therapies's Waste Recovery Rate

20%

How much of Intra-Cellular Therapies's waste is recycled or recovered?

In 2023, Intra-Cellular Therapies reported a total waste generation of 2 metric tonnes, of which 20% was recovered through recycling, reuse, or composting.This low recovery rate highlights limited waste diversion and suggests that Intra-Cellular Therapies may be relying more heavily on landfill or incineration, underscoring opportunities for stronger resource recovery initiatives.a

Insights into Intra-Cellular Therapies’s Generation of Hazardous and Non-Hazardous Waste

In 2023, Intra-Cellular Therapies generated a total of 2 metric tonnes of waste.a

Of this amount, 80% of Intra-Cellular Therapies's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment.20% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.a

Want Full Access to Intra-Cellular Therapies's Waste Management Dataset?
Start 30-Day Free Trial